Summa Equity completed the investment in UgenTec.

Summa Equity, a Nordic private equity firm, completed the investment in UgenTec, a Belgian/US based SaaS software provider that provides molecular diagnostic labs worldwide with AI-based software solutions for sample flow management, result analysis & interpretation, and lab QC & insights. Financial terms were not disclosed. "We are extremely pleased to join the Summa portfolio, since we share a data-driven vision for diagnostic testing and precision medicine. Contemporary molecular diagnostics now requires optimizing lab and healthcare workflows with smart software automation and unlocking valuable operational, research and clinical insights in diagnostic lab data through AI and data science," Steven Verhoeven, UgenTec CEO.